Daily Stock List
KollagenX Corp. (KGNX)
MoneyTV, Investors Alley, and StreetAuthorityFinancial reported on KollagenX Corp. (KGNX), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed KollagenX Corp. is an advanced skin care development and marketing enterprise. The Company’s principal focus is nano gold technology, also called NGT®. KollagenX develops and introduces new, safe, more affordable eco-friendly NGT® products that it believes will help improve the quality of lives. KollagenX is based in Chino Hills, California. Founded in 2008, the Company previously went by the name Integrated Electric Systems Corp. It changed its corporate name to KollagenX Corp. in July of 2014.
KollagenX® Nano Gold Technology (NGT®) has recognition for its ability to ward off UV damage, tighten lax skin, and reduce the appearance of discoloration spotted skin. This is in addition to its antioxidant and antimicrobial abilities. KollagenX helps bring the nourishment one’s skin requires to be healthier and function more effectively. The Company says that its inventive anti-aging skin care products restore a natural youthful glow and a smoother, suppler appearance
The Company indicates that KollagenX® (NGT®) promotes increased circulation, assists in eliminating toxins from the body, and speeds up tissue repair. It promotes the growth of the skin cells through replacing the aging cells for revitalization.
KollagenX’s Collection includes 24KT Gold Face Mask, 24KT Gold Under-Eye’s, 24KT Gold Eye Serum, 24KT Gold Hydrating Cream, 24KT Gold Cleanser, and 24KT Gold Lip Gloss. KollagenX Nano Gold is 99.999 percent pure gold. It is free of any hazardous metal elements. Moreover, it is 1/2000 the size of an average pore, therefore easily penetrating into the dermis.
KollagenX® has received approval for their 24KT Nano Gold product line from the Ministry of Health of Kuwait. Approval was granted to import product to Kuwait.
KollagenX announced in November 2015 that its Management engaged Samson Pharmaceuticals to expand its 24KT Gold Skin Care Collection. KollagenX’s belief is that Samson Pharmaceuticals is the right fit for KollagenX®. Samson Pharmaceuticals is Food and Drug Administration (FDA) registered and a drug licensed laboratory in the U.S., presently manufacturing a varied product line ranging from OTC (Over-the-Counter), cosmetics, to dietary supplements and others.
KollagenX Corp. (KGNX), closed Friday's trading session at $0.0032, down 8.57%, on 2,614,086 volume with 46 trades. The average volume for the last 60 days is 1,502,249 and the stock's 52-week low/high is $0.0025/$0.64.
SPYR, Inc. (SPYR)
OTCJournal, SmallCapNetwork, Winston Small Cap, Orbit Stocks, Shiznit Stocks, Penny Stock Beats, and MyBestStockAlerts reported on SPYR, Inc. (SPYR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Incorporated in 1988, SPYR, Inc. is a holding company that lists on the OTC Markets’ OTCQB. The Company has wholly-owned subsidiaries in the mobile game and app development & publishing industry, and also the restaurant industry. Currently, SPYR is exploring opportunities for additional acquisitions in these and other verticals. This includes mobile application and game development, to expand its holdings, to drive and grow revenue and to generate profits and build value for shareholders.
SPYR has its headquarters in Denver, Colorado. The Company was previously known as Eat at Joe’s, Ltd. It changed its name to SPYR, Inc. in March of 2015.
Through its wholly-owned subsidiary, SPYR APPS, LLC, the Company engages in mobile application and game development. Additionally, SPYR owns and operates an "American Diner" theme restaurant located in the Philadelphia International Airport in Philadelphia, Pennsylvania, named "Eat at Joe's®" through its other wholly-owned subsidiary, E.A.J.: PHL Airport, Inc.
In essence, SPYR builds a portfolio of platforms, and subsequently works to send consumers to those platforms. The aim is for advertisers to pay to advertise to those consumers. With each new online brand/website that it develops or acquires, it is, fundamentally, producing an additional platform for advertisers to place ads that subsequently produces revenue for SPYR.
SPYR’s subsidiary, SPYR APPS, entered into an agreement with SuperPlus Games to co-publish its new game, Retro Shot. This is a retro arcade game fully equipped with neon lights, an 80's synthwave soundtrack, free-to-play game mechanics and monetization.
SuperPlus Games is a Finnish company. It was established by former Rovio employees who were part of the team that developed "Angry Birds". The development team describes Retro Shot as an innovative combination of mini golf and 80's pinball games.
Last month, SPYR announced the global launch of Retro Shot, the mobile game published by its wholly-owned subsidiary, SPYR APPS, in collaboration with the game's developer, SuperPlus Games. Retro Shot was successfully launched in the Google Play Store and the Apple App Store on February 25, 2016.
SPYR, Inc. (SPYR), closed Friday's trading session at $0.13, up 4.00%, on 106,100 volume with 9 trades. The average volume for the last 60 days is 19,273 and the stock's 52-week low/high is $0.1201/$0.99.
Star Century Pandaho Corp. (SCPD)
StockHideout, TryBestPennyStocks.biz, and SmallCapAllStars reported on Star Century Pandaho Corp. (SCPD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Star Century Pandaho Corp.’s theme culture is based on Pandaho, the Panda, and the Company is spreading the culture, brand name exposition, series products production, and sales of Pandaho, the Panda. Star Century Pandaho has its corporate headquarters in Las Vegas, Nevada. The Company previously went by the name Journal Of Radiology, Inc. It changed its name to Star Century Pandaho Corp. in January of 2015.
Star Century Pandaho also operates the fan club of Pandaho, the Panda, which is advancing the image of the national treasures of China, the Panda, and developing and launching commercial, philanthropy, as well as cultural activities. Star Century Pandaho’s emphasis is on providing its services in China, the Asia-Pacific countries, the U.S., and Canada.
In essence, the Company’s business model includes the formation of official and professional fan clubs for celebrities. These clubs will engage in event management, talent shows, music festivals, and movie productions. In addition, its planned operations will include the aforementioned Pandaho (Panda) themed areas, which include branding, toys, art, entertainment, as well as e-commerce.
In November 2015, Star Century Pandaho announced that it signed a strategic cooperation agreement with Pisona Tour Company Limited, the owner and operator of Patong Bay Hill, a hotel in Thailand, comprising upwards to 350 residence units, sixteen shops and facilities. With this agreement, Patong Bay Hill will use the Pandaho as its mascot, provide the lowest prices for SCPD Pandaho's members and also sell Pandaho related licensed products to its guests.
This week, Star Century Pandaho announced that its intention is to expand its business in China. The Company will be based on the theme of Pandaho products of the Pandaho to life class with FMCG focus. Franchise opportunities come under the name of PANDAHO LIFE. The Pandaho series of design focuses on the surrounding Chinese life and other cultural and creative home products that the middle class rapidly consumes each day.
Star Century Pandaho’s plan is to develop the territory with a minimum of 10 stores (company-owned and franchised) this year. This is upon approval of Chinese regulators.
Star Century Pandaho Corp. (SCPD), closed Friday's trading session at $0.49, up 104.17%, on 11,919 volume with 10 trades. The average volume for the last 60 days is 2,933 and the stock's 52-week low/high is $0.20/$1.00.
Trans Energy, Inc. (TENG)
Wall Street Resources and Wyatt Investment Research reported previously on Trans Energy, Inc. (TENG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Trans Energy, Inc.’s intention is to focus its development and exploration efforts in its Marcellus properties. Furthermore, the Company’s intention is to use its acreage position to expand its reserve base through continued exploratory and development drilling of the Marcellus Shale for this year and beyond. Trans Energy is based in St. Marys, West Virginia. The Company’s shares trade on the OTC Markets Group’s OTCQB.
The Company plans to utilize the latest drilling, completion, and fracturing technology in all of its wells. This is to enhance recoverability and accelerate cash flows associated with these wells. Trans Energy’s belief is that its broad acreage position will permit it to grow by way of high risk drilling in the near term.
Trans Energy’s business strategy is to grow its oil and gas reserves and production. It seeks to do so while keeping its development costs and operating costs as low as possible. The Company stated that it will implement this strategy through drilling exploratory and development wells from its inventory of available prospects that it has evaluated for geologic and mechanical risk and future reserve or resource potential.
Trans Energy’s emphasis is principally in Marshall, Wetzel and Marion Counties in West Virginia. The Company and its Joint Venture (JV) Partner, Republic Energy, own interests in, and operate roughly 62,000 gross acres in West Virginia. Trans Energy’s highly predictable and repeatable drilling inventory is situated in the liquids-rich portion in the core area of the Marcellus Shale in West Virginia.
In Marshall County, Trans Energy and JV Partner Republic Energy hold interests in 12,367 gross acres of leased and owned minerals. In Wetzel County, Trans Energy and Republic Energy hold interests in 28,659 gross acres of leased and owned minerals. In Marion County, Trans Energy and Republic Energy hold interests in 20,302 gross acres of leased and owned minerals.
EFactor Group Corp. (TENG), closed Friday's trading session at $1.00, up 100.00%, on 1,600 volume with 4 trades. The average volume for the last 60 days is 2,060 and the stock's 52-week low/high is $0.35/$3.20.
Cerebain Biotech Corp. (CBBT)
Greenbackers reported previously on Cerebain Biotech Corp. (CBBT), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Cerebain Biotech Corp. focuses on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution. A development-stage medical device enterprise, the Company formerly went by the name Discount Dental Materials, Inc. It changed its name to Cerebain Biotech Corp. in June 2014. Cerebain Biotech is based in Dallas, Texas.
The Company’s device takes advantage of the clinically observable, positive impact that omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimer’s disease. Its patent-pending device is implanted in the omentum, which is a protective layer of skin that protects the abdominal organs. The design of the device is to stimulate the omentum in patients with Alzheimer’s Disease. Omental stimulation has been shown to improve cognitive function in patients with dementias. This includes Alzheimer’s Disease.
Concerning Cerebain’s technology, it has allowed for the development of a medical device, which can be implanted using a minimally invasive procedure. Upon implantation, through what will probably be a same-day surgery procedure, patients may not have to undergo surgery again using this treatment method. Cerebain Biotech has a manufacturing agreement with Sonos Medical, a medical device supplier.
Cerebain said that its research suggests it has three options for implantable devices with a predisposition towards having them as non-invasive as possible. The options consist of two electro-stim types that have a multitude of variable test parameters that can be changed and modified externally as the testing facility conducts clinical trials on each patient. Cerebain said that manufacturing should begin this year.
Cerebain Biotech’s intention is to strategically prepare for the start of its clinical trial studies in 2016. This includes necessary filings and strategic partnerships. Furthermore, it plans to allocate resources to administer grant applications for further research and testing of its existing technology.
In addition, it plans to design a surgical manual to be used by doctors and clinicians for the purpose of implanting its medical device. Moreover, its plan includes providing additional administrative and financial support to its scientists to leverage their time to advance Cerebain’s technologies in or near trials.
Recently, Cerebain Biotech announced the appointment of Mr. Richmond Webb to chair its Sports Awareness Committee. Mr. Eric Clemons, Cerebain Biotech President and Chief Executive Officer, said, “Richmond has had an exemplary football career and is an astute investor with attractive business acumen. He has been and is involved in a number of worthwhile ventures. We are honored to have him associated with Cerebain and serving on our Sports Awareness Committee.”
Cerebain Biotech Corp. (CBBT), closed Friday's trading session at $0.2899, up 7.37%, on 320 volume with 2 trades. The average volume for the last 60 days is 5,099 and the stock's 52-week low/high is $0.18/$1.00.
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.01955, up 19.21%, on 1,827,998 volume with 68 trades. The stock’s average daily volume over the past 60 days is 1,428,733 and its 52-week low/high is $0.0035/$0.339.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report
Dominovas Energy Agrees to Acquire Grupo Trebol in Guatemala City, Guatemala
Dominovas Energy Signs Financing Agreement With GHS Capital
Alternet Systems, Inc. (ALYI)
The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.0091, up 13.75%, on 73,500 volume with 7 trades. The stock’s average daily volume over the past 60 days is 115,357, and its 52-week low/high is $0.0055/$0.029.
Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.
Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets
Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.
Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.
With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.
As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer
Alternet Systems, Inc. Company Blog
Alternet Systems, Inc. News:
Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners
Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation
Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base
eXp Realty International Corp. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp Realty International Corp. (EXPI). Today, eXp Realty International Corp. closed trading at $1.573, up 8.48%, on 16,900 volume with 22 trades. The stock’s average daily volume over the past 60 days is 9,430, and its 52-week low/high is $0.44/$2.20.
eXp Realty International Corp. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp Realty International Corp. Company Blog
eXp Realty International Corp. News:
eXp Realty International Corporation Announces Name Change to eXp World Holdings, Inc.
eXp Realty International Corporation Enters Into Agreement With VirBELA, LLC
eXp Realty International Corporation Appoints COO and CFO
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $4.00, even for the day, on 1,696 volume with 18 trades. The stock’s average daily volume over the past 60 days is 5,875, and its 52-week low/high is $1.25/$11.625.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results
International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial
International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $1.05, up 8.25%, on 13,572 volume with 6 trades. The stock’s average daily volume over the past 60 days is 5,079, and its 52-week low/high is $0.60/$1.05.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
Ourpet's Company Reaches a Settlement With Competitor Over Durapet(R) Patents
OurPet's Company Unveils New Innovative Products at Global Pet Expo 2016
OurPet's Company Reports Record 2015 Fourth Quarter and Full-Year Results
Today's Top 3
Fortune Stock Alerts
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs MOU to Acquire Revenue-Producing Company
- Dominovas Energy Corp. (DNRG) Recognized as Leader in Expanding Fuel Cell Applications in U.S. Department of Energy (DOE) Report
- Ecosciences, Inc. (ECEZ) Signs Distributor Agreement With Everglades Supply Co, Inc.
- eXp Realty International Corp. (EXPI) Announces Name Change to eXp World Holdings, Inc.
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
- GTX Corp. (GTXO) SeeThruEquity Issues Update on GTX Corp. Highlighting Patent Portfolio and Expanding Distribution
- Halitron, Inc. (HAON) Generates Over $1M in Sales
- Immune Therapeutics, Inc. (IMUN) Using the Power of the Body to Fight Cancer and AIDS
- International Stem Cell Corp. (ISCO) Announces 2015 Fourth Quarter and Year-End Results
- Laguna Blends Inc. (LAGBF) Introduces Pro369 Hemp Protein Beverage and Expands to Over 700 Independent Affiliates
- Lingo Media Corp. (LMDCF) to Present at the 2016 Microcap Conference Toronto on April 12th
- Moxian, Inc. (MOXC) Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate
- Oakridge Global Energy Solutions, Inc. (OGES) Successful First Quarter Q1, 2016 Revenues Exceed Guidance
- OurPet's Company (OPCO) Reaches a Settlement With Competitor Over Durapet(R) Patents
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust